SAVAS PAUL G 4
4 · vTv Therapeutics Inc. · Filed Dec 7, 2017
Insider Transaction Report
Form 4
SAVAS PAUL G
Director
Transactions
- Purchase
Class A common stock
2017-12-06$4.55/sh+10,000$45,500→ 81,781 total - Purchase
Class A common stock
2017-12-07$4.57/sh+5,000$22,857→ 86,781 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $4.23 to $4.79, inclusive. The reporting person undertakes to provide to vTv Therapeutics Inc. (the "Issuer"), any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $4.52 to $4.60, inclusive